Trastulli, Fabio (2022) UTILIZZO DELLA CONTRAST-ENHANCED ULTRASOUND (CEUS) CON ESAFLUORURO DI ZOLFO NELL’IDENTIFICAZIONE DELL’INVASIONE SPLENICA DA LINFOMA. STUDIO MONOCENTRICO DI 260 NODULI. [Tesi di dottorato]

[thumbnail of Trastulli_Fabio_XXXV.pdf]
Preview
Text
Trastulli_Fabio_XXXV.pdf

Download (5MB) | Preview
Item Type: Tesi di dottorato
Resource language: Italiano
Title: UTILIZZO DELLA CONTRAST-ENHANCED ULTRASOUND (CEUS) CON ESAFLUORURO DI ZOLFO NELL’IDENTIFICAZIONE DELL’INVASIONE SPLENICA DA LINFOMA. STUDIO MONOCENTRICO DI 260 NODULI
Creators:
Creators
Email
Trastulli, Fabio
f.trastulli@gmail.com
Date: 12 December 2022
Number of Pages: 27
Institution: Università degli Studi di Napoli Federico II
Department: Medicina Clinica e Chirurgia
Dottorato: Terapie avanzate biomediche e chirurgiche
Ciclo di dottorato: 35
Coordinatore del Corso di dottorato:
nome
email
Pane, Fabrizio
fabrizio.pane@unina.it
Tutor:
nome
email
Picardi, Marco
UNSPECIFIED
Date: 12 December 2022
Number of Pages: 27
Keywords: CEUS LINFOMA NON HOGKIN LINFOMA DI HODGKIN INTERESSAMENTO SPLENICO
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/15 - Malattie del sangue
Date Deposited: 06 Mar 2023 07:50
Last Modified: 09 Apr 2025 14:11
URI: http://www.fedoa.unina.it/id/eprint/14675

Collection description

Contrast-enhanced ultrasonography (CEUS) use for detecting lymphoma in the spleen was questioned because of the risk of its inadequate diagnostic accuracy. The aim of the present study was to validate CEUS exam for the identification of spleen involvement by lymphoma in patients at risk. A total of 260 nodules from the spleens of 77 patients with lymph node biopsy-proven non-Hodgkin lymphoma (NHL; n = 44) or Hodgkin lymphoma (HL; n = 33) at staging (n = 56) or follow-up (n = 21) were collected in a hematology Italian center and retrospectively analyzed. Nodules were classified as malignant lymphoma if ≥0.5 cm (long axis) with arterial phase isoen-hancement and early (onset <60 s after contrast agent injection) wash-out of marked (≤120 s after contrast agent injection) degree. Other perfusional combinations at CEUS scans qualified lesions as benign or inconclusive. Diagnostic reference standard was clinical laboratory imaging monitoring for 230 nodules, and/or histology for 30 nodules. The median nodule size was 1.5 cm (range 0.5-7 cm). According to the reference standard, 204 (78%) nodules were lymphomas (aggressive-NHL (a-NHL), 122; classic-HL (c-HL), 65; indolent (i)-NHL, 17) and 56 (22%) were benign (inflammation, infection, and/or mesenchymal) lesions. Sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy of CEUS for detecting lymphoma in the spleen were 95%, 100%, 100%, 85%, and 96%, respectively. Marked wash-out range of 55-90 s (median, 74 s), 92-120 s (median, 100 s), and 101-120 s (median, 114.5 s) was 100%, 96.6%, and 77% predictive of a-NHL, c-HL, and i-NHL splenic nodular infiltration, respectively. The CEUS perfusional pattern of arterial phase isoenhancement with early wash-out of marked degree was highly accurate for the detection of lymphomatous invasion of spleen in patients at risk, enabling its use for a confident non-invasive diagnosis.

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item